Skyrizi 360mg/2.4ml Solution for Injection PFC 1's - (Upon Request)

Skyrizi (risankizumab) is an interleukin-23 (IL-23) antagonist used in adults for:

Moderate to severe plaque psoriasis (candidates for systemic therapy or phototherapy).

Active psoriatic arthritis.

Moderately to severely active Crohn’s disease.

Moderately to severely active ulcerative colitis.